TRCT
TECH icon

Tower Research Capital (TRC)’s Bio-Techne TECH Stock Holding History

Tower Research Capital (TRC)’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$130K Sell
2,481
-477
-16% -$28.6K ﹤0.01% 1977
2025
Q4 		$174K Buy
2,958
+1,801
+156% +$109K ﹤0.01% 1547
2025
Q3 		$64.4K Sell
1,157
-721
-38% -$38.6K ﹤0.01% 2325
2025
Q2 		$96.6K Sell
1,878
-1,162
-38% -$58.4K ﹤0.01% 2407
2025
Q1 		$178K Sell
3,040
-7,783
-72% -$527K 0.01% 1434
2024
Q4 		$780K Buy
10,823
+7,129
+193% +$523K 0.02% 773
2024
Q3 		$295K Sell
3,694
-15,940
-81% -$1.2M 0.01% 1268
2024
Q2 		$1.41M Buy
19,634
+15,117
+335% +$1.11M 0.02% 569
2024
Q1 		$318K Sell
4,517
-27,861
-86% -$1.99M 0.01% 1123
2023
Q4 		$2.5M Buy
32,378
+19,530
+152% +$1.29M 0.03% 442
2023
Q3 		$875K Buy
12,848
+3,198
+33% +$253K 0.03% 594
2023
Q2 		$788K Buy
9,650
+3,316
+52% +$267K 0.03% 663
2023
Q1 		$469K Buy
6,334
+3,417
+117% +$263K 0.01% 867
2022
Q4 		$242K Sell
2,917
-13,631
-82% -$1.08M 0.01% 1187
2022
Q3 		$1.18M Sell
16,548
-8,560
-34% -$740K 0.02% 637
2022
Q2 		$2.18M Sell
25,108
-2,084
-8% -$195K 0.05% 344
2022
Q1 		$2.94M Buy
27,192
+19,796
+268% +$2.04M 0.03% 468
2021
Q4 		$956K Buy
7,396
+2,624
+55% +$322K 0.02% 726
2021
Q3 		$578K Sell
4,772
-19,508
-80% -$2.37M 0.01% 882
2021
Q2 		$2.73M Buy
24,280
+19,436
+401% +$2.05M 0.07% 217
2021
Q1 		$463K Sell
4,844
-3,484
-42% -$318K 0.01% 1301
2020
Q4 		$661K Sell
8,328
-864
-9% -$62.6K 0.02% 794
2020
Q3 		$569K Sell
9,192
-29,484
-76% -$1.92M 0.01% 1547
2020
Q2 		$2.55M Buy
38,676
+33,848
+701% +$2.03M 0.1% 165
2020
Q1 		$229K Sell
4,828
-2,816
-37% -$141K 0.01% 690
2019
Q4 		$419K Buy
7,644
+3,116
+69% +$163K 0.03% 323
2019
Q3 		$222K Sell
4,528
-3,056
-40% -$153K 0.02% 946
2019
Q2 		$395K Buy
7,584
+2,052
+37% +$103K 0.03% 579
2019
Q1 		$275K Buy
5,532
+4,864
+728% +$219K 0.02% 987
2018
Q4 		$24K Sell
668
-18,176
-96% -$759K ﹤0.01% 1799
2018
Q3 		$962K Buy
18,844
+4,428
+31% +$196K 0.07% 211
2018
Q2 		$533K Buy
14,416
+1,196
+9% +$45.7K 0.03% 617
2018
Q1 		$499K Buy
13,220
+11,600
+716% +$410K 0.04% 473
2017
Q4 		$53K Buy
1,620
+872
+117% +$27.7K 0.01% 1307
2017
Q3 		$23K Sell
748
-812
-52% -$24.1K ﹤0.01% 2652
2017
Q2 		$46K Buy
1,560
+840
+117% +$23K 0.01% 790
2017
Q1 		$18K Sell
720
-256
-26% -$6.61K ﹤0.01% 1369
2016
Q4 		$25K Sell
976
-2,588
-73% -$68K ﹤0.01% 1942
2016
Q3 		$98K Buy
3,564
+3,440
+2,774% +$94.5K 0.01% 835
2016
Q2 		$3K Buy
+124
New +$3.19K ﹤0.01% 3742
2016
Q1 		– Sell
-1,516
Closed -$34K – 4917
2015
Q4 		$34K Sell
1,516
-1,540
-50% -$35.1K 0.01% 778
2015
Q3 		$71K Buy
+3,056
New +$76.6K 0.01% 782
2015
Q1 		– Sell
-13,356
Closed -$309K – 4917
2014
Q4 		$309K Buy
+13,356
New +$306K 0.03% 197
2014
Q3 		– Sell
-6,748
Closed -$156K – 4878
2014
Q2 		$156K Sell
6,748
-84
-1% -$1.86K 0.02% 694
2014
Q1 		$146K Buy
6,832
+2,224
+48% +$50K 0.02% 523
2013
Q4 		$109K Sell
4,608
-4,500
-49% -$97.5K 0.02% 813
2013
Q3 		$182K Buy
+9,108
New +$173K 0.02% 813

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Tower Research Capital (TRC)'s TECH Position: Q1 2026 in Review

Tower Research Capital (TRC) reduced its Bio-Techne (TECH) stake by 16% in Q1 2026, selling an estimated $28.6K and leaving 2,481 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #1977.

Tower Research Capital (TRC) first reported a position in TECH in Q3 2013 and has held it in 47 quarters since. The position peaked at $2.94M in Q1 2022. 582 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Tower Research Capital (TRC) held 2,481 shares of Bio-Techne worth $130K as of Q1 2026.
  • Tower Research Capital (TRC) sold 477 Bio-Techne shares in Q1 2026, an estimated $28.6K.
  • Bio-Techne made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #1977 holding.
  • Tower Research Capital (TRC) first reported a position in Bio-Techne in Q3 2013 and has held it in 47 quarters since.
  • Tower Research Capital (TRC)'s Bio-Techne position peaked at $2.94M in Q1 2022.
  • 582 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.